Head-to-Head

Bristol-Myers Squibb Co. vs. Eli Lilly & Co.

BMY

Bristol-Myers Squibb Co.

$62.84 -1.19%

VS LLY

Eli Lilly & Co.

$1152.44 +1.28%

Eli Lilly & Co. (LLY) comes out ahead, leading on 6 of 11 compared factors.

Size & Scale

BMYLLY
Market Cap $129.92 billion $1.03 trillion
Revenue (TTM) $49.19 billion $79.67 billion
Net Income (TTM) $9.27 billion $26.71 billion

LLY leads on 3 of 3 size & scale factors.

Valuation

BMYLLY
P/E Ratio 13.84 38.69
Price / Book 5.82 30.32
Price / Sales 2.64 12.89

BMY leads on 3 of 3 valuation factors.

Profitability

BMYLLY
Net Margin 18.85% 33.53%
Return on Equity 41.55% 78.84%

LLY leads on 2 of 2 profitability factors.

Dividend

BMYLLY
Dividend Yield 4.01% 0.60%
Payout Ratio 55.51 23.23

BMY and LLY split the dividend factors evenly.

Risk & Sentiment

BMYLLY
Short Interest 0.39% 1.29%

BMY leads on 1 of 1 risk & sentiment factors.

Dig deeper: BMY overview, BMY financials, LLY overview, LLY financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.